{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T09:34:52Z","timestamp":1779183292624,"version":"3.51.4"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["UO1NS041588"],"award-info":[{"award-number":["UO1NS041588"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["K24HL111154"],"award-info":[{"award-number":["K24HL111154"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01HL080477"],"award-info":[{"award-number":["R01HL080477"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000901","name":"JDRF","doi-asserted-by":"publisher","award":["3-SRA-2014-302-M-R"],"award-info":[{"award-number":["3-SRA-2014-302-M-R"]}],"id":[{"id":"10.13039\/100000901","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["diabetesresearchclinicalpractice.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.diabres.2016.01.021","type":"journal-article","created":{"date-parts":[[2016,1,15]],"date-time":"2016-01-15T14:10:03Z","timestamp":1452867003000},"page":"115-121","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"special_numbering":"C","title":["Calcium channel blocker use is associated with lower fasting serum glucose among adults with diabetes from the REGARDS study"],"prefix":"10.1016","volume":"115","author":[{"given":"Yulia","family":"Khodneva","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anath","family":"Shalev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stuart J.","family":"Frank","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"April P.","family":"Carson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monika M.","family":"Safford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.diabres.2016.01.021_bib0100","doi-asserted-by":"crossref","first-page":"S97","DOI":"10.2337\/diabetes.54.suppl_2.S97","article-title":"Mechanisms of pancreatic beta-cell death in type 1 and type 2 diabetes: many differences, few similarities","volume":"54","author":"Cnop","year":"2005","journal-title":"Diabetes"},{"issue":"6","key":"10.1016\/j.diabres.2016.01.021_bib0105","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.2337\/dc14-0396","article-title":"Beta-cell failure in type 2 diabetes: postulated mechanisms and prospects for prevention and treatment","volume":"37","author":"Halban","year":"2014","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.diabres.2016.01.021_bib0110","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.2337\/diabetes.50.2007.S58","article-title":"Beta-cell apoptosis: stimuli and signaling","volume":"50","author":"Mandrup-Poulsen","year":"2001","journal-title":"Diabetes"},{"issue":"4","key":"10.1016\/j.diabres.2016.01.021_bib0115","doi-asserted-by":"crossref","first-page":"848","DOI":"10.2337\/db11-0955","article-title":"Preventing beta-cell loss and diabetes with calcium channel blockers","volume":"61","author":"Xu","year":"2012","journal-title":"Diabetes"},{"issue":"5","key":"10.1016\/j.diabres.2016.01.021_bib0120","doi-asserted-by":"crossref","first-page":"E1133","DOI":"10.1152\/ajpendo.90944.2008","article-title":"Diabetes induces and calcium channel blockers prevent cardiac expression of proapoptotic thioredoxin-interacting protein","volume":"296","author":"Chen","year":"2009","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.diabres.2016.01.021_bib0125","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1159\/000086678","article-title":"The reasons for geographic and racial differences in stroke study: objectives and design","volume":"25","author":"Howard","year":"2005","journal-title":"Neuroepidemiology"},{"issue":"16\u201317","key":"10.1016\/j.diabres.2016.01.021_bib0130","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.clinbiochem.2014.08.003","article-title":"Validating laboratory results in a national observational cohort study without field centers: the Reasons for Geographic and Racial Differences in Stroke cohort","volume":"47","author":"Gillett","year":"2014","journal-title":"Clin Biochem"},{"issue":"1","key":"10.1016\/j.diabres.2016.01.021_bib0135","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/00005650-198601000-00007","article-title":"Concurrent and predictive validity of a self-reported measure of medication adherence","volume":"24","author":"Morisky","year":"1986","journal-title":"Med Care"},{"issue":"15","key":"10.1016\/j.diabres.2016.01.021_bib0140","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1001\/jama.2011.468","article-title":"Detection of chronic kidney disease with creatinine, cystatin C, and urine albumin-to-creatinine ratio and association with progression to end-stage renal disease and mortality","volume":"305","author":"Peralta","year":"2011","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.diabres.2016.01.021_bib0145","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/j.1751-7176.2011.00513.x","article-title":"Calcium channel blockers","volume":"13","author":"Elliott","year":"2011","journal-title":"J Clin Hypertens"},{"issue":"6","key":"10.1016\/j.diabres.2016.01.021_bib0150","first-page":"IV31","article-title":"Use of calcium channel entry blockers in the treatment of cardiac arrhythmias","volume":"80","author":"Akhtar","year":"1989","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.diabres.2016.01.021_bib0155","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1055\/s-2006-939925","article-title":"Diagnosis and treatment of cluster headache","volume":"26","author":"Capobianco","year":"2006","journal-title":"Semin Neurol"},{"issue":"1","key":"10.1016\/j.diabres.2016.01.021_bib0160","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s11940-012-0208-3","article-title":"Familial and sporadic hemiplegic migraine: diagnosis and treatment","volume":"15","author":"Pelzer","year":"2013","journal-title":"Curr Treat Opt Neurol"},{"issue":"7","key":"10.1016\/j.diabres.2016.01.021_bib0165","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.amjcard.2006.04.030","article-title":"Predictors of development of diabetes mellitus in patients with coronary artery disease taking antihypertensive medications (findings from the INternational VErapamil SR-Trandolapril STudy [INVEST])","volume":"98","author":"Cooper-Dehoff","year":"2006","journal-title":"Am J Cardiol"},{"issue":"5","key":"10.1016\/j.diabres.2016.01.021_bib0170","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.ahj.2005.05.024","article-title":"Blood pressure control and cardiovascular outcomes in high-risk Hispanic patients\u2014findings from the International Verapamil SR\/Trandolapril Study (INVEST)","volume":"151","author":"Cooper-DeHoff","year":"2006","journal-title":"Am Heart J"},{"issue":"10","key":"10.1016\/j.diabres.2016.01.021_bib0175","doi-asserted-by":"crossref","first-page":"3581","DOI":"10.1096\/fj.08-111690","article-title":"Thioredoxin-interacting protein deficiency induces Akt\/Bcl-xL signaling and pancreatic beta-cell mass and protects against diabetes","volume":"22","author":"Chen","year":"2008","journal-title":"FASEB J"},{"issue":"4","key":"10.1016\/j.diabres.2016.01.021_bib0180","doi-asserted-by":"crossref","first-page":"938","DOI":"10.2337\/db07-0715","article-title":"Thioredoxin-interacting protein: a critical link between glucose toxicity and beta-cell apoptosis","volume":"57","author":"Chen","year":"2008","journal-title":"Diabetes"},{"issue":"17","key":"10.1016\/j.diabres.2016.01.021_bib0185","doi-asserted-by":"crossref","first-page":"11807","DOI":"10.1074\/jbc.M113.525022","article-title":"Thioredoxin-interacting protein promotes islet amyloid polypeptide expression through miR-124a and FoxA2","volume":"289","author":"Jing","year":"2014","journal-title":"J Biol Chem"},{"issue":"8","key":"10.1016\/j.diabres.2016.01.021_bib0190","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.2337\/dc09-1727","article-title":"The effect of oral antidiabetic agents on A1C levels: a systematic review and meta-analysis","volume":"33","author":"Sherifali","year":"2010","journal-title":"Diabetes Care"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016882271600070X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016882271600070X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,16]],"date-time":"2018-09-16T01:00:05Z","timestamp":1537059605000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016882271600070X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":19,"alternative-id":["S016882271600070X"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2016.01.021","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Calcium channel blocker use is associated with lower fasting serum glucose among adults with diabetes from the REGARDS study","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2016.01.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}